Andrea Bink

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Hypoxia-targeted BOLD MRI signal heterogeneity as a complementary metric for glioblastoma characterization: a pilot study.

Hypoxia-targeted BOLD MRI signal heterogeneity as a complementary metric for glioblastoma characterization: a pilot study.

Journal: Journal of neuro-oncology

Published: May 31, 2026

Prediction of treatment failure in patients with glioblastoma with perfusion MRI and molecular biomarkers.

Prediction of treatment failure in patients with glioblastoma with perfusion MRI and molecular biomarkers.

Journal: Neuro-oncology advances

Published: March 01, 2026

Transition from In-Person to Online Boards-An Exploratory Pilot Study on Pituitary Tumor Board Meetings.

Transition from In-Person to Online Boards-An Exploratory Pilot Study on Pituitary Tumor Board Meetings.

Journal: Journal of clinical medicine

Published: February 12, 2026

Postsurgical detection of glioma recurrence using MRI radiomics.

Postsurgical detection of glioma recurrence using MRI radiomics.

Journal: Neuro-oncology advances

Published: November 05, 2025

Three-Dimensional quantitative analysis of the Peri-Enhancing zone reveals ADC and CBV signatures of glioblastoma recurrence.

Three-Dimensional quantitative analysis of the Peri-Enhancing zone reveals ADC and CBV signatures of glioblastoma recurrence.

Journal: NeuroImage. Clinical

Published: October 02, 2025

Adaptation of an arterial spin labeling sequence for the assessment of brain perfusion on a 0.35 T MR-Linac.

Adaptation of an arterial spin labeling sequence for the assessment of brain perfusion on a 0.35 T MR-Linac.

Journal: Magma (New York, N.Y.)

Published: July 02, 2025

The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant.

The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant.

Journal: Neuro-oncology

Published: January 22, 2025

Long survival in a patient with fumarate hydratase mutation-associated glioma.

Long survival in a patient with fumarate hydratase mutation-associated glioma.

Journal: Journal of neuropathology and experimental neurology

Published: September 16, 2024

Targeted radionuclide therapy for gliomas: Emerging clinical trial landscape.

Targeted radionuclide therapy for gliomas: Emerging clinical trial landscape.

Journal: Neuro-oncology

Published: August 06, 2024

Towards fair decentralized benchmarking of healthcare AI algorithms with the Federated Tumor Segmentation (FeTS) challenge.

Towards fair decentralized benchmarking of healthcare AI algorithms with the Federated Tumor Segmentation (FeTS) challenge.

Journal: Nature communications

Published: June 29, 2024

Advanced Distance-Resolved Evaluation of the Perienhancing Tumor Areas with FLAIR Hyperintensity Indicates Different ADC Profiles by MGMT Promoter Methylation Status in Glioblastoma.

Advanced Distance-Resolved Evaluation of the Perienhancing Tumor Areas with FLAIR Hyperintensity Indicates Different ADC Profiles by MGMT Promoter Methylation Status in Glioblastoma.

Journal: AJNR. American journal of neuroradiology

Published: June 02, 2024

A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol.

A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol.

Journal: BMC cancer

Published: December 09, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026